L-Pyroglutamic acid

Details

Top
Internal ID 55a5619b-e338-4ff1-8408-2851f429611d
Taxonomy Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Alpha amino acids and derivatives
IUPAC Name (2S)-5-oxopyrrolidine-2-carboxylic acid
SMILES (Canonical) C1CC(=O)NC1C(=O)O
SMILES (Isomeric) C1CC(=O)N[C@@H]1C(=O)O
InChI InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1
InChI Key ODHCTXKNWHHXJC-VKHMYHEASA-N
Popularity 5,127 references in papers

Physical and Chemical Properties

Top
Molecular Formula C5H7NO3
Molecular Weight 129.11 g/mol
Exact Mass 129.042593085 g/mol
Topological Polar Surface Area (TPSA) 66.40 Ų
XlogP -0.80
Atomic LogP (AlogP) -0.65
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 1

Synonyms

Top
98-79-3
Pidolic acid
Pyroglutamic acid
5-OXOPROLINE
5-oxo-L-proline
H-Pyr-OH
(S)-5-Oxopyrrolidine-2-carboxylic Acid
(2S)-5-oxopyrrolidine-2-carboxylic acid
Pyroglutamate
pyroglu
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of L-Pyroglutamic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9150 91.50%
Caco-2 - 0.9028 90.28%
Blood Brain Barrier + 0.7500 75.00%
Human oral bioavailability + 0.6857 68.57%
Subcellular localzation Mitochondria 0.7605 76.05%
OATP2B1 inhibitior - 0.8423 84.23%
OATP1B1 inhibitior + 0.9568 95.68%
OATP1B3 inhibitior + 0.9509 95.09%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.9846 98.46%
P-glycoprotein inhibitior - 0.9916 99.16%
P-glycoprotein substrate - 0.9777 97.77%
CYP3A4 substrate - 0.7102 71.02%
CYP2C9 substrate - 0.5955 59.55%
CYP2D6 substrate - 0.8648 86.48%
CYP3A4 inhibition - 0.9931 99.31%
CYP2C9 inhibition - 0.9782 97.82%
CYP2C19 inhibition - 0.9812 98.12%
CYP2D6 inhibition - 0.9678 96.78%
CYP1A2 inhibition - 0.9641 96.41%
CYP2C8 inhibition - 0.9864 98.64%
CYP inhibitory promiscuity - 0.9973 99.73%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.7189 71.89%
Eye corrosion - 0.9647 96.47%
Eye irritation + 0.8914 89.14%
Skin irritation - 0.8518 85.18%
Skin corrosion - 0.9020 90.20%
Ames mutagenesis - 0.9200 92.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8095 80.95%
Micronuclear + 0.5200 52.00%
Hepatotoxicity + 0.9000 90.00%
skin sensitisation - 0.9390 93.90%
Respiratory toxicity - 0.5889 58.89%
Reproductive toxicity + 0.6667 66.67%
Mitochondrial toxicity - 0.5625 56.25%
Nephrotoxicity - 0.6893 68.93%
Acute Oral Toxicity (c) III 0.8003 80.03%
Estrogen receptor binding - 0.9053 90.53%
Androgen receptor binding - 0.9280 92.80%
Thyroid receptor binding - 0.9153 91.53%
Glucocorticoid receptor binding - 0.8865 88.65%
Aromatase binding - 0.8514 85.14%
PPAR gamma - 0.7351 73.51%
Honey bee toxicity - 0.9770 97.70%
Biodegradation + 0.9000 90.00%
Crustacea aquatic toxicity - 0.8400 84.00%
Fish aquatic toxicity - 0.9566 95.66%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293235 P02545 Prelamin-A/C 5.6 nM
5.6 nM
Potency
Potency
via CMAUP
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 97.54% 83.82%
CHEMBL2581 P07339 Cathepsin D 86.86% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 86.15% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.67% 95.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.12% 99.23%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 83.42% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.82% 94.45%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 80.27% 93.00%

Cross-Links

Top
PubChem 7405
NPASS NPC19576
ChEMBL CHEMBL397976
LOTUS LTS0142947
wikiData Q60998677